JBT MAREL Corp

Rule 10b5-1 Trading Plans

During the three months ended March 31, 2026, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement,” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.

Appointment of Officer

On April 29, 2026, the Board of Directors appointed Andrew Moller as the Company’s Vice President and Chief Accounting Officer, effective as of June 1, 2026. Mr. Moller, age 51, will serve as the Company’s principal accounting officer. Mr. Moller has served as Vice President and Corporate Controller of CONMED Corporation, a medical device manufacturer, since January 2025. Previously, Mr. Moller served in several roles at Smith & Nephew plc, a medical technology manufacturer: Vice President, Finance Transformation from January 2024 through December 2025, Chief Financial Officer, Asia Pacific Group from April 2023 to February 2024, Vice President Finance – Global Controller from January 2023 through March 2023, Chief Financial Officer, Global ENT from January 2022 through March 2023, and Vice President Finance, Americas Controller from January 2020 to January 2023.

As Vice President and Chief Accounting Officer, Mr. Moller will receive an annual salary of $410,000. Mr. Moller will be eligible to participate in the Company’s short-term incentive compensation program, with a target annual incentive award of 45% of his base salary. Mr. Moller will also be eligible to participate in the Company’s long-term incentive compensation program, with a target annual grant value of $200,000, starting in 2027. Mr. Moller will receive an initial grant of restricted stock units in June 2026 with a value of $100,000. The restricted stock units will have the same vesting conditions as those awarded to other officers under the Company’s long-term incentive compensation program. Additionally, Mr. Moller will receive certain relocation benefits and will be eligible for certain employee benefits generally available to employees at a similar level.

There are no arrangements or understandings between Mr. Moller and any other persons pursuant to which he was selected as an officer of the Company. Mr. Moller has no family relationships with any of the Company’s directors or executive officers or any persons nominated or chosen by the Company to become a director or executive officer, and he has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.